You are here

  • Home
  • Archive
  • Volume 72, Issue Suppl 3
  • FRI0089 Assessing maintenance of remission with reduced dose etanercept plus methotrexate, methotrexate alone, or placebo in patients with early rheumatoid arthritis who achieved remission with etanercept and methotrextate: the prize study

Article info

Article menu
Download PDFPDF
Poster Presentation
Rheumatoid arthritis - prognosis, predictors and outcome
FRI0089 Assessing maintenance of remission with reduced dose etanercept plus methotrexate, methotrexate alone, or placebo in patients with early rheumatoid arthritis who achieved remission with etanercept and methotrextate: the prize study

Authors

Citation

Emery P, Hammoudeh M, FitzGerald O, et al
FRI0089 Assessing maintenance of remission with reduced dose etanercept plus methotrexate, methotrexate alone, or placebo in patients with early rheumatoid arthritis who achieved remission with etanercept and methotrextate: the prize study
Annals of the Rheumatic Diseases 2013;72:A399.

Publication history

  • First published January 23, 2014.
Online issue publication 
February 21, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2013, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions